Background: Tuberculosis is one of the transmitted diseases that has been claimed as
one of the most serious health problems worldwide resulting in death, as reported in WHO in
Global Tuberculosis Report 2014. It has been predicted that 9 million people suffer from tuberculosis
disease and 1.5 - 2 million deaths occur by this disease.
Objective: The aim of this research is to know the species of plant used as anti-hematemesis
medicine that has the activity of antituberculosis and antituberculosis-MDR and then investigate
the phytochemistry characteristics of the compound from every parts of the plant extract that show
the activity of antituberculosis and antituberculosis-MDR which is indicated by the value of
Minimum Inhibitory Concentration (MIC) of the extracts.
Methods: The extraction method used in this research was the maceration method. The antituberculosis
activity test was investigated using MODS and LJ media methods. The isolation of the active
compound was carried out using Bioassay Guided Fractionation and then the compound characteristics
were identified using spectroscopy data.
Results: The results showed that extracts from Talas (Collocasia esculenta tuber) and Kariango
(Acorus calamus rhizome) plants were active against M. tuberculosis. The FTIR spectroscopy data
showed that three isolates obtained from Talas plants contained aliphatic OH and C-O and CH
groups. The MIC values of kariango and Talas extracts using the MODS method were 45 mg/ml
and 40 mg/ml, respectively.
Conclusion: Talas (Collocasia esculenta) tuber and Kariango rhizome ethanolic extract have a
potency for antituberculosis and anti-MDR tuberculosis drugs.